Hemant Surgical Industries Ltd. (HSIL) 52 Week High Streak: HSIL trades near yearly peak for second straight session
- September 25, 2026
- Posted by: Chaitanya Auti
- Category: News
Hemant Surgical Industries Ltd. (HSIL) has now traded within 2% of its 52-week high for its second straight session, with the stock moving 0.8% across the streak and holding near the latest peak of Rs 620. The latest Univest figures confirm the pattern, but they do not establish a company-specific catalyst for the repeated near-high trading.
HSIL last traded at Rs 620 versus the previous close of Rs 613.55, after opening at Rs 600 and touching a low of Rs 600 during the morning session. The market capitalisation stood at Rs 894.14 crore. For readers tracking the HSIL 52 Week High Streak, the main point is not just the single-day move; it is the persistence of the price near the yearly high across sessions.
HSIL 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 620 |
| Previous Close | Rs 613.55 |
| Today's Move | +Rs 6.45 (+1.05%) |
| Open | Rs 600 |
| High | Rs 620 |
| Low | Rs 600 |
| Market Capitalisation | Rs 894.14 crore |
Hemant Surgical Industries Ltd. (HSIL) traded at Rs 620 versus the previous close of Rs 613.55, a rise of 1.05%. The stock opened at Rs 600, reached a high of Rs 620 and touched a low of Rs 600.
HSIL share price today shows a modest step higher, with the stock last traded at Rs 620, up Rs 6.45 or 1.05% from the previous close of Rs 613.55. The day opened at Rs 600 and the low also stood at Rs 600, while the high matched the latest price at Rs 620. That places the stock at the upper end of the intraday band as of 25 September 2026 at 10:48 AM IST.
For investors following HSIL stock news, this is a straightforward price update rather than a claim of a fresh record. The current move keeps HSIL share price close to its yearly high and extends the HSIL 52 Week High Streak into a second straight session. The market capitalisation of Rs 894.14 crore gives context to the move, but the session itself remains a price-led event. On a day like this, the key question is whether the stock can continue to hold near the top of its range while the repeated high pattern develops.
What the Repeated 52-Week Highs Show
The HSIL 52 Week High Streak points to a stock that has stayed close to its one-year peak across consecutive sessions rather than simply printing one isolated high point. The latest near-high reading is supported by a cumulative gain of 0.8% across the streak, which is the main differentiator from a single-day breakout story. That cumulative move is small, but it is still important because it shows the price has remained near the same elevated zone over more than one session.
For readers searching for HSIL New One Year High or HSIL Back To Back 52 Week Highs, the factual read is that the pattern is confirmed, while the reason behind it is not. The data confirms repeated near-high trading, but it does not identify a fresh event, announcement or market trigger. That makes this a useful watchlist case for Stocks Hitting 52 Week Highs, not because a decisive catalyst has been named, but because the repeated behaviour itself can matter to market participants who track price persistence.
Hemant Surgical Industries Ltd. (HSIL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 894.14 crore |
| P/E Ratio | 49.03x |
| P/B Ratio | 6.2x |
| ROE | 12.73% |
| ROCE | 13.58% |
| EPS | Rs 12.51 |
| Book Value Per Share | Rs 98.98 |
| Dividend Yield | 0% |
Hemant Surgical Industries Ltd. (HSIL) fundamental metrics show P/E 49.03x, P/B 6.2x, ROE 12.73%, ROCE 13.58%. These figures provide context only and are not a buy or sell signal.
Hemant Surgical Industries Ltd. has a market capitalisation of Rs 894.14 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.03x, P/B at 6.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.73% and ROCE of 13.58%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.51, book value per share of Rs 98.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.71x, median ROE of 14.07%, median ROCE of 15.05%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 49.03x |
| Benchmark Median P/E | 28.71x |
| Benchmark Average P/E | 89.66x |
| Benchmark P/E Range | 0x to 1,051.05x |
| Company P/B Ratio | 6.2x |
| Benchmark Median P/B | 3.8x |
| Company ROE | 12.73% |
| Benchmark Median ROE | 14.07% |
| Company ROCE | 13.58% |
| Benchmark Median ROCE | 15.05% |
| Company Market Capitalisation | Rs 894.14 crore |
| Benchmark Median Market Cap | Rs 178.8 crore |
Hemant Surgical Industries Ltd. (HSIL) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 49.03x, which is above the benchmark median of 28.71x, a difference of +70.78%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Hemant Surgical Industries Ltd. (HSIL) has a ROE of 12.73%, which is below the benchmark median of 14.07%, a difference of -9.52%. Hemant Surgical Industries Ltd. (HSIL) has a ROCE of 13.58%, which is below the benchmark median of 15.05%, a difference of -9.77%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,076.65 | 35.05 | 4.41 | 11.95 | 13.29 |
| Osel Devices Ltd. | OSELDEVICE | 695.5 | 23.78 | 6.35 | 30.09 | 31.15 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,230.37 | 21.78 | 4.32 | 19.41 | 26.03 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,631.92 | 28.25 | 6.22 | 25.55 | 22.23 |
| Prevest Denpro Ltd. | PREVEST | 460.56 | 20.94 | 3.49 | 17.79 | 24.21 |
Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 49.03x compared with the displayed peer median of 23.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.73% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 13.58% versus the displayed peer median of 24.21%, providing a capital-efficiency comparison. Hemant Surgical Industries Ltd. (HSIL) has a market capitalisation of Rs 894.14 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching HSIL
- HSIL 52 Week High Streak has continued for a second straight session, keeping the stock near its yearly high.
- The cumulative move across the streak is 0.8%, which helps separate the pattern from a one-day spike.
- HSIL share price today last traded at Rs 620, above the previous close of Rs 613.55.
- The company’s P/E and P/B both sit above the same-industry medians, which keeps HSIL stock analysis focused on valuation.
- HSIL remains part of the Healthcare and medical equipment universe, where Stocks At One Year High Today often stay on active watchlists.
About HSIL
Hemant Surgical Industries Ltd. is part of the Healthcare sector and operates in the Medical Equipment/Supplies/Accessories industry. The company’s latest market capitalisation is Rs 894.14 crore, and its published ratios show a business with moderate profitability and a premium market valuation versus the industry median. For readers checking HSIL company news, the stock’s current market placement is as relevant as the day’s price movement.
HSIL’s latest share price behaviour keeps it in the centre of the Stocks In News Today conversation, especially for investors who track Stocks At One Year High Today and extended streaks. The company’s valuation, earnings profile and peer context provide a framework for watching whether the near-high pattern continues or slows.
Frequently Asked Questions
What does HSIL 52 Week High Streak mean?
It means HSIL has traded within 2% of its 52-week high for consecutive sessions. In this case, the stock has done so for a second straight session, which makes the repeated near-high pattern the main point of interest.
Has HSIL set a new 52-week high today?
The latest figures show HSIL trading near its 52-week high, but the article does not claim a fresh record was set. The key fact is the repeated proximity to that high across sessions.
How much has HSIL moved across the streak?
HSIL has moved 0.8% across the streak so far. That cumulative change is the best way to read the repeated near-high pattern rather than focusing only on the latest session move.
What is HSIL share price today?
HSIL last traded at Rs 620, up Rs 6.45 or 1.05% from the previous close of Rs 613.55. The stock also touched an intraday high of Rs 620 during the morning session.
Is HSIL expensive compared with peers?
HSIL trades at a P/E of 49.03 and a P/B of 6.2, both above the same-industry medians. That places the stock at a premium valuation compared with many peers in the medical equipment industry.
What do HSIL’s ROE and ROCE show?
HSIL’s ROE is 12.73 and ROCE is 13.58. Both are below the peer medians in the same industry set, so the valuation premium is not matched by the strongest profitability ranking.
Why are investors watching HSIL stock news now?
Investors are watching because the stock has stayed near its yearly high for a second straight session. That makes HSIL a notable case within Stocks Hitting 52 Week Highs and other Stocks At One Year High Today searches.
What should investors monitor next in HSIL?
Investors should monitor whether HSIL continues to trade near its 52-week high and whether the valuation premium is supported by future company performance. The repeated near-high pattern is confirmed, but the reason for it is not.
Track Hemant Surgical Industries Ltd. (HSIL) Share Price on Univest
Use Hemant Surgical Industries Ltd. (HSIL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.